US$ 28.57
bpc-157 oral vs injectable effectiveness comparison Bpc 157 Banned Is Banned? vs. Forms Explained bpc-157 oral vs injectable effectiveness
Description
Lower volumes are more concentrated and use fewer syringe units

For administration, the peptide requires subcutaneous injection into the abdomen (the preferred site, 2 inches from the navel), upper thighs, or upper arms
The charts below are built around this principle

doi: 10.31887/DCNS.2007.9.2/mpucak

Bloodwork may be recommended based on the peptide and treatment goal

Adding 2 mL to 50 mg gives a concentration of 25 mg/mL
